Japan Again Postpones Approval Of Shionogi COVID Antiviral

Decision To Await Phase III Data

MHLW's Discussion gathered nation-wide attention in Japan
Two-hour long discussion by MHLW gathered nation-wide attention • Source: Lisa Takagi
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia